TerminatedNCT00592358
Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolarity
Researchers are studying paliperidone to find out how it affects manic symptoms in children and adolescents with bipolarity type II during a manic episode.
Medication studyAges 6–17United States
Understand this study
What is this study about?
Researchers are studying paliperidone to find out how it affects manic symptoms in children and adolescents with bipolarity type II during a manic episode.
Who could participate?
Listed age limits: 6 years to 17 years.
- Listed locations
- CambridgeSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNovember 2007
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 17
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT00592358
- Official title
Show the full official title
Open-Label Study of Invega for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cambridge
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are studying paliperidone to find out how it affects manic symptoms in children and adolescents with bipolarity type II during a manic episode.
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including paliperidone.
Who can participate?
Listed age limits: 6 years to 17 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Depression in bipolarity
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolarity type I.